HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O Manzke Selected Research

Antibodies

2/2001Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses.
1/2001Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O Manzke Research Topics

Disease

4Neoplasms (Cancer)
09/2002 - 05/2000
3B-Cell Lymphoma (Lymphoma, B Cell)
02/2001 - 05/2000
2Lymphoma (Lymphomas)
09/2002 - 05/2000
1Chills
09/2002
1Hypotension (Low Blood Pressure)
09/2002
1Nausea
09/2002
1Hodgkin Disease (Hodgkin's Disease)
09/2001
1Infertility (Sterility)
09/2001
1Neuroblastoma
01/2001
1Multiple Myeloma
03/2000

Drug/Important Bio-Agent (IBA)

4Bispecific AntibodiesIBA
02/2001 - 05/2000
3Monoclonal AntibodiesIBA
09/2002 - 05/2000
2AntibodiesIBA
02/2001 - 01/2001
2AntigensIBA
01/2001 - 03/2000
1Rituximab (Mabthera)FDA Link
09/2002
1Alkylating AgentsIBA
09/2001
1RicinIBA
01/2001
1Immunotoxins (Immunotoxin)IBA
01/2001
1CytokinesIBA
05/2000
1Radioisotopes (Radionuclides)IBA
05/2000
1ParaproteinsIBA
03/2000
1EpitopesIBA
03/2000
1Immunoglobulins (Immunoglobulin)IBA
03/2000

Therapy/Procedure

2Aftercare (After-Treatment)
09/2002 - 09/2001
2Therapeutics
09/2002 - 09/2001
2Radiotherapy
09/2002 - 05/2000
2Drug Therapy (Chemotherapy)
09/2001 - 05/2000